HiPPO H1 CGM – Next-Generation Continuous Glucose Monitoring System

The HiPPO H1 CGM (Continuous Glucose Monitoring System) is an innovative glucose monitoring solution that provides accurate, real-time glucose readings without the need for frequent fingerstick testing.

Designed for everyday use, HiPPO H1 helps people with diabetes better understand their glucose trends and make informed treatment decisions while enabling healthcare professionals to monitor patients more efficiently.

High Accuracy with 3rd Generation Enzyme Technology

HiPPO H1 incorporates advanced sensor technology combined with 3rd Generation Enzyme Technology to deliver:

• High measurement accuracy
• Stable performance throughout the sensor wear period
• Reliable real-time glucose readings
• Improved clinical decision support

Consistent and accurate glucose monitoring helps optimize diabetes management and improve patient outcomes.

14 Days of Continuous Glucose Monitoring

The sensor provides continuous glucose monitoring for up to 14 days, allowing users to benefit from:

• 24/7 glucose monitoring
• Better understanding of glucose trends
• Improved therapy management
• Greater convenience with fewer interruptions

Real-Time Glucose Alerts

HiPPO H1 instantly notifies users through the mobile application about:

• Hypoglycemia
• Hyperglycemia
• Rapid glucose rise
• Rapid glucose fall

These alerts help users respond quickly and reduce the risk of severe glucose events.

Small, Comfortable and Discreet Sensor

The compact sensor is designed for maximum comfort and convenience.

Its ergonomic design allows users to:

• Wear it comfortably throughout daily activities
• Maintain an active lifestyle
• Enjoy discreet use under clothing
• Experience reliable performance with minimal interference

Data Sharing with Family Members and Healthcare Professionals

HiPPO H1 enables secure sharing of glucose data in real time with:

• Family members
• Caregivers
• Physicians
• Diabetes specialists
• Healthcare professionals

This feature supports remote monitoring and facilitates better patient care.

Smart Digital Ecosystem

HiPPO H1 is supported by a complete digital ecosystem, including mobile applications and a cloud-based management platform.

Healthcare professionals gain access to:

• Comprehensive glucose reports
• AGP Reports
• Historical glucose data
• Trend analysis
• Time in Range (TIR)
• Clinical decision support tools

This enables faster evaluation of patient progress and more effective diabetes management.

Unlimited Follow

The Unlimited Follow feature allows healthcare providers and caregivers to monitor multiple users simultaneously, making it an ideal solution for:

• Diabetes clinics
• Hospitals
• Medical centers
• Endocrinology practices
• Families managing diabetes

Apple Watch Compatibility

Users can conveniently monitor their glucose values directly from their Apple Watch, providing instant access to glucose information anytime and anywhere.

Certified for Children Aged 3 Years and Above

HiPPO H1 is clinically validated and certified for use in children aged 3 years and older.

Manufactured with skin-friendly materials and highly accurate sensor technology, it offers safe, reliable glucose monitoring for children and adolescents while supporting parents and healthcare professionals in everyday diabetes care.